Shanghai Rendu Biotechnology Co., Ltd.

SHSE:688193 Stock Report

Market Cap: CN¥1.1b

Shanghai Rendu Biotechnology Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Minghui Yu

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

There Are Some Holes In Shanghai Rendu Biotechnology's (SHSE:688193) Solid Earnings Release

May 06
There Are Some Holes In Shanghai Rendu Biotechnology's (SHSE:688193) Solid Earnings Release

We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)

Apr 17
We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)

What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You

Mar 08
What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You

CEO

Minghui Yu (41 yo)

no data

Tenure

CN¥2,048,000

Compensation

Ms. Minghui Yu is GM & Director of Shanghai Rendu Biotechnology Co., Ltd.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.